## Abstract The immunogenic effect of inactivated hepatitis B vaccine (Merck Heptavax B) was evaluated in 202 seronegative healthy medical personnel. Three inoculations of vaccine were given at 1‐month intervals. Of 116 vaccinees who received a 40‐μg dose, 39% had an anti‐HBs response 1 month after
Immunogenic effect of inactivated hepatitis B vaccine: Comparison of 20 μg and 40 μg doses
✍ Scribed by Saul Krugman; H. Preston Holley Jr.; Morton Davidson; Michael S. Simberkoff; Nicolas Matsaniotis
- Publisher
- John Wiley and Sons
- Year
- 1981
- Tongue
- English
- Weight
- 166 KB
- Volume
- 8
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
An outbreak of nonbacterial gastroenteritis occurred in an orphanage in December 1979. Of 54 residents, 43 were affected with acute gastroenteritis. Diarrhea was the commonest symptom. The 33‐ to 39‐nm virus‐like particles, tentatively designated as Sapporo agent, were detected in 17 (48.6%) of the patients' 35 fecal specimens. Morphologically, it was difficult to distinguish the Sapporo agent from other agents without geometrical pattern on the surface. Antigenically, the Sapporo agent related to the Otofuke agent detected in an outbreak of the institution for mentally retarded adults and also to the SRV '76 detected in familial cases of infectious gastroenteritis. The Sapporo agent might belong to a new group of those gastroenteritis viruses which were larger in size than the Norwalk virus group.
📜 SIMILAR VOLUMES
The immunogenic effect of hepatitis B vaccine (H-B-vax) was evaluated in 120 seronegative healthy Nigerians. Three doses of the vaccine were given at 0, 1, and 6 months. Serial blood samples were tested I month after each vaccination for hepatitis B surface antibody (anti-HBs) and antibody to hepati
In a randomized controlled trial, 165 healthy medical students were immunized either by the intramuscular route (IM group) or by the intradermal route (ID group) with low-dose (2 micrograms) plasma hepatitis B vaccine (HB-VAX) at months 0, 1, 2, and 6. At month 7, protective immunity (anti-HBs great
The immunogenic effect of hepatitis B vaccine was evaluated in 183 seronegative infants from Senegal. Seventy-two seronegative infants received two 5-micrograms doses of vaccine at a two-month interval and 111 seronegative infants received three 5-micrograms doses at one-month intervals. All the chi